Invesco Biotechnology & Genome ETF
PBE
PBE
108 hedge funds and large institutions have $88.2M invested in Invesco Biotechnology & Genome ETF in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
Holders
108
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.73M | |
| 2 | +$1.35M | |
| 3 | +$1.32M | |
| 4 |
Two Sigma Investments
New York
|
+$696K |
| 5 |
LPL Financial
San Diego,
California
|
+$357K |
Top Sellers
| 1 | -$361K | |
| 2 | -$250K | |
| 3 | -$239K | |
| 4 |
DWM
Dakota Wealth Management
Palm Beach Gardens,
Florida
|
-$224K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$206K |
